Table 5. Distribution of the ototopic scores for therapy resistant CSOM patients treated with P60.4Ac-containing ototopical drops and placebo drops during treatment and follow-up.
| P60.4Ac | Placebo | ||
|---|---|---|---|
| Visit | Score | n (%) | n (%) |
| Week 0 | 3 | 12 (71) | 12 (71) |
| 2 | 2 (12) | 2 (12) | |
| 1 | 3 (18) | 3 (18) | |
| 0 | 0 (0) | 0 (0) | |
| Week 4 | 3 | 3a (19)a | 10 (59) |
| 2 | 8a (50)a | 4 (24) | |
| 1 | 3a (19)a | 2 (12) | |
| 0 | 2a (13)a | 1 (6) | |
| Week 8 | 3 | 3 (18) | 12 (971) |
| 2 | 6 (35) | 3 (18) | |
| 1 | 5 (29) | 2 (12) | |
| 0 | 3 (18) | 0 (0) | |
| Week 12 | 3 | 4 (24) | 10a (63) |
| 2 | 4 (24) | 3a (19) | |
| 1 | 3 (18) | 3a (19) | |
| 0 | 6 (35) | 0a (0) |
Results are otoscopic scores at visit. Each group comprised 17 patients.
a Data for 1 subject is missing. Scores: 3: thickened, polypoid mucosa with viscous mucous discharge; 2: thickened, polypoid, dry or discharging mucosa; 1: flat, discharging mucosa; 0: flat, dry mucosa.